APG Asset Management N.V. raised its holdings in shares of Hologic, Inc. (NASDAQ:HOLX) by 31.7% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 136,751 shares of the medical equipment provider’s stock after buying an additional 32,923 shares during the period. APG Asset Management N.V.’s holdings in Hologic were worth $5,017,000 as of its most recent SEC filing.
A number of other large investors have also modified their holdings of the stock. Vanguard Group Inc. boosted its holdings in Hologic by 4.2% during the second quarter. Vanguard Group Inc. now owns 29,547,138 shares of the medical equipment provider’s stock worth $1,340,850,000 after buying an additional 1,200,825 shares in the last quarter. Capital World Investors acquired a new position in Hologic in the 2nd quarter worth approximately $312,441,000. Victory Capital Management Inc. boosted its stake in Hologic by 23.7% in the 2nd quarter. Victory Capital Management Inc. now owns 5,012,352 shares of the medical equipment provider’s stock worth $227,461,000 after purchasing an additional 961,528 shares during the period. Bank of Montreal Can boosted its stake in Hologic by 6.6% in the 2nd quarter. Bank of Montreal Can now owns 3,418,319 shares of the medical equipment provider’s stock worth $155,123,000 after purchasing an additional 211,550 shares during the period. Finally, Northern Trust Corp boosted its stake in Hologic by 2.5% in the 2nd quarter. Northern Trust Corp now owns 3,277,739 shares of the medical equipment provider’s stock worth $148,743,000 after purchasing an additional 79,697 shares during the period. Hedge funds and other institutional investors own 95.68% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This story was first posted by Community Financial News and is the property of of Community Financial News. If you are reading this story on another website, it was illegally stolen and republished in violation of U.S. and international copyright & trademark legislation. The original version of this story can be viewed at https://www.com-unik.info/2017/11/05/apg-asset-management-n-v-raises-position-in-hologic-inc-holx.html.
A number of research firms recently commented on HOLX. Needham & Company LLC reaffirmed a “buy” rating and issued a $50.00 price objective on shares of Hologic in a research note on Friday. Zacks Investment Research raised shares of Hologic from a “sell” rating to a “hold” rating in a research note on Tuesday, October 31st. Jefferies Group LLC reaffirmed a “buy” rating and issued a $44.00 price objective (down previously from $49.00) on shares of Hologic in a research note on Tuesday, October 10th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $45.00 price objective (down previously from $48.00) on shares of Hologic in a research note on Monday, October 9th. Finally, Royal Bank Of Canada reaffirmed a “hold” rating and issued a $42.00 price objective on shares of Hologic in a research note on Friday, September 22nd. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $47.77.
In related news, Director Lawrence M. Levy sold 9,596 shares of Hologic stock in a transaction on Tuesday, October 10th. The shares were sold at an average price of $36.81, for a total value of $353,228.76. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Lawrence M. Levy sold 7,138 shares of Hologic stock in a transaction on Monday, October 9th. The stock was sold at an average price of $37.38, for a total transaction of $266,818.44. The disclosure for this sale can be found here. Insiders have sold a total of 23,873 shares of company stock worth $898,754 in the last 90 days. 0.79% of the stock is owned by insiders.
Hologic, Inc. (NASDAQ:HOLX) opened at $39.56 on Friday. The firm has a market cap of $11,095.55, a price-to-earnings ratio of 19.39, a PEG ratio of 1.74 and a beta of 0.93. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.65 and a current ratio of 0.85. Hologic, Inc. has a twelve month low of $35.76 and a twelve month high of $46.80.
Hologic (NASDAQ:HOLX) last released its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.50 earnings per share for the quarter, beating analysts’ consensus estimates of $0.49 by $0.01. The business had revenue of $806.10 million for the quarter, compared to the consensus estimate of $799.70 million. Hologic had a net margin of 25.65% and a return on equity of 23.18%. Hologic’s revenue for the quarter was up 12.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.51 EPS. sell-side analysts forecast that Hologic, Inc. will post 2.01 earnings per share for the current fiscal year.
Hologic Company Profile
Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays.
What are top analysts saying about Hologic Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Hologic Inc. and related companies.